Primary systemic amyloidosis in patients with Waldenström macroglobulinemia-Reference-Cited by-同舟云学术

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

Published:2018-10-12 Issue:3 Volume:33 Page:790-794
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Zanwar Saurabh^ORCID,Abeykoon Jithma P.,Ansell Stephen M.,Gertz Morie A.,Dispenzieri Angela,Muchtar Eli^ORCID,Sidana Surbhi^ORCID,Tandon Nidhi^ORCID,Rajkumar S. Vincent,Dingli David,Go Ronald^ORCID,Lacy Martha Q.,Kourelis Taxiarchis,Witzig Thomas E.,Inwards David,Buadi Francis,Gonsalves Wilson,Habermann Thomas,Johnston Patrick,Nowakowski Grzegorz,Kyle Robert A.,Kumar Shaji^ORCID,Kapoor Prashant

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0286-7.pdf

Reference15 articles.

1. Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, et al. Diagnosis and Management of Waldenstrom Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016. JAMA Oncol. 2017;3:1257–65.

2. Gertz MA, Buadi FK, Hayman SR. IgM amyloidosis: clinical features in therapeutic outcomes. Clin Lymphoma Myeloma Leuk. 2011;11:146–8.

3. Wechalekar AD, Lachmann HJ, Goodman HJ, Bradwell A, Hawkins PN, Gillmore JD. AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcome. Blood. 2008;112:4009–16.

4. Palladini G, Russo P, Bosoni T, Sarais G, Lavatelli F, Foli A, et al. AL amyloidosis associated with IgM monoclonal protein: a distinct clinical entity. Clin Lymphoma Myeloma. 2009;9:80–3.

5. Kourelis TV, Kumar SK, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, et al. Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis. J Clin Oncol. 2013;31:4319–24.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia;Journal of Clinical Oncology;2024-07-20

2. Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, risk stratification, and clinical problems.;Mediterranean Journal of Hematology and Infectious Diseases;2024-06-29

3. Assessment of Tp-Te interval in patients with cardiac AL amyloidosis;CARDIOVASC J AFR;2024

4. A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee;International Journal of Hematology;2023-07-29

5. Central nervous system involvement (Bing-Neel Syndrome) in patients with Waldenström macroglobulinemia;Leukemia & Lymphoma;2023-06-10